SGLT2 inhibitors versus GLP-1 receptor agonists and risk of kidney replacement therapy and healthcare utilization in bipolar disorder with chronic kidney disease: An active-comparator, new-user cohort study
- DOI
- 10.1016/j.jad.2026.122407
- Published
- 2026-12
- Container
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jad.2026.122407,
title = {SGLT2 inhibitors versus GLP-1 receptor agonists and risk of kidney replacement therapy and healthcare utilization in bipolar disorder with chronic kidney disease: An active-comparator, new-user cohort study},
author = {Balwinder Singh and Feyza Yaylaci and Hossam M. Ali and Ritika Baweja and Maria L. Gonzalez Suarez and Raman Baweja},
year = {2026},
journal = {Journal of Affective Disorders},
doi = {10.1016/j.jad.2026.122407},
url = {https://doi.org/10.1016/j.jad.2026.122407}
}RIS
TY - JOUR TI - SGLT2 inhibitors versus GLP-1 receptor agonists and risk of kidney replacement therapy and healthcare utilization in bipolar disorder with chronic kidney disease: An active-comparator, new-user cohort study AU - Balwinder Singh AU - Feyza Yaylaci AU - Hossam M. Ali AU - Ritika Baweja AU - Maria L. Gonzalez Suarez AU - Raman Baweja PY - 2026 JO - Journal of Affective Disorders DO - 10.1016/j.jad.2026.122407 UR - https://doi.org/10.1016/j.jad.2026.122407 ER -
APA
Singh, B., Yaylaci, F., Ali, H. M., Baweja, R., Suarez, M. L. G., & Baweja, R. (2026). SGLT2 inhibitors versus GLP-1 receptor agonists and risk of kidney replacement therapy and healthcare utilization in bipolar disorder with chronic kidney disease: An active-comparator, new-user cohort study. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2026.122407
Source records
- crossref · retrieved 2026-09-27T04:59:47.869Z